{"id":"W2440371401","doi":"10.1111/ajco.12513","title":"An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non–small cell lung cancer","year":2016,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Pemetrexed; Medicine; Cisplatin; Hazard ratio; Etoposide; Internal medicine; Oncology; Carboplatin; Chemotherapy; Confidence interval; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004763161,0.00118941,0.002206984,0.0004326834,0.0003272394,0.0008630917,0.0004374858,0.0006896736,0.001894358],"category_scores_gemma":[0.002453519,0.000328315,0.006664138,0.0005635193,0.0003736007,0.0005128329,0.0004568724,0.001140423,0.0002172008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006187924,"about_ca_system_score_gemma":0.001151819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001023655,"about_ca_topic_score_gemma":0.003737238,"domain_scores_codex":[0.9984599,0.0008404856,0.0002435987,0.000209994,0.0001098073,0.0001361174],"domain_scores_gemma":[0.9987524,0.000333941,0.0003427942,0.0002763192,0.0001258262,0.0001687582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8150547,0.001353346,0.0529362,0.002667686,0.07627568,0.0003811773,0.0003383606,0.001292911,0.00973448,0.0002867009,0.001763136,0.03791576],"study_design_scores_gemma":[0.4176286,0.06682495,0.1843494,0.0004768112,0.30867,0.00083026,0.0007668244,0.004185985,0.008867986,0.00106379,0.006185626,0.0001498788],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893003,0.007434909,0.0006225472,0.0003025229,0.0001609119,0.0005746337,0.0007288699,0.00002318903,0.0008522897],"genre_scores_gemma":[0.9956282,0.001304588,0.0005855778,0.0005088462,0.000112624,0.0004777586,0.0007096942,0.0000130561,0.0006596556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004763161,"threshold_uncertainty_score":0.02519029,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03462318452454766,"score_gpt":0.4324831263084926,"score_spread":0.397859941783945,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}